Lonza Group Ltd
O6Z
Company Profile
Business description
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Contact
Muenchensteinerstrasse 38
Basel4002
CHET: +41 613168111
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
19,299
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,220.80 | 35.80 | -0.39% |
CAC 40 | 7,974.85 | 3.07 | 0.04% |
DAX 40 | 24,385.78 | 7.49 | 0.03% |
Dow JONES (US) | 46,602.98 | 91.99 | -0.20% |
FTSE 100 | 9,483.58 | 4.44 | 0.05% |
HKSE | 26,957.77 | 183.15 | -0.67% |
NASDAQ | 22,788.36 | 153.30 | -0.67% |
Nikkei 225 | 48,096.55 | 145.67 | 0.30% |
NZX 50 Index | 13,537.58 | 6.29 | 0.05% |
S&P 500 | 6,714.59 | 25.69 | -0.38% |
S&P/ASX 200 | 8,927.90 | 30.50 | -0.34% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |